Fig. 3: Effect of oxytocin treatment on emotion recognition from point-light displays. | Translational Psychiatry

Fig. 3: Effect of oxytocin treatment on emotion recognition from point-light displays.

From: Oxytocin treatment attenuates amygdala activity in autism: a treatment-mechanism study with long-term follow-up

Fig. 3: Effect of oxytocin treatment on emotion recognition from point-light displays.

Mean changes from baseline in task performance (accuracy/reaction time) on the emotion task are visualized separately for the oxytocin (IN-OT) and placebo (PL) treatment groups. Changes in task-performance are visualized separately for each emotional state (happiness, anger) and assessment session: SD (after a single-dose administration), T1 (immediately after the 4-week, multiple-dose treatment), T2 (at follow-up, 4 weeks post-treatment), and T3 (at follow-up, one year post-treatment). Vertical bars denote ±standard errors. On the right, an exemplary point-light display is visualized, consisting of 12 white dots moving against a black background, representing the motion of the main joints of the human body (ankles, knees, hips, wrists, elbows, and shoulders).

Back to article page